By Chris Bavender
The Pedcor Square Building in the Carmel City Center will soon be the new home of Indigo BioAutomation’s company headquarters. The company – which provides automated data analysis, data management and data integration solutions to clinical laboratories, pharmaceutical and biotechnology research laboratories and laboratories in other life science markets – will occupy all of the second floor of the building, approximately 9,700 square feet.
Company founder and CEO Randall Julian said several factors went into the decision, including the fact the current lease in northwest Indianapolis was due to expire and a desire to relocate to the north side where many employees live.
“Our Chief Operating Officer, Sharon Mcilwaine, did an analysis from input gathered from the entire company about what type of space and locale would make a great workplace,” Julian said. “Some of the criteria included the ability for our employees to have easy access to running and biking trails and proximity to lunch spots for weekly team gatherings.”
Julian said City Center scored “high marks” for those factors, plus it provided a workplace with a combination of private and collaborative work areas.
“This location puts us in the heart of the activity with enough existing structures immediately around our new office without having to be in the center of continued development in the area,” he said.
Indigo BioAutomation has 32 full-time employees. Julian said the company is growing and hiring is underway.
“Our main product has a significant share of the laboratory data analysis market, and we expect precision medicine and data analytics to be an increasingly important tool for health care, so we expect that market to continue growing,” he said. “Further, we are working on new technologies to improve food safety and to fight the opioid epidemic. If we are successful with these initiatives we could see very rapid growth and need a much larger team.”
In the next five years, Julian said there will be a complete change in the way laboratory medicine is done, and he expects the company to “help improve human health by making increasingly direct and complex molecular measurements available to everyone, everywhere.”
“We think that the next decade will produce technologies that eclipse the self-driving car and the smart hone, because your health and your family’s health is more important than all those other products combined,” he said.
Indigo BioAutomation is scheduled to begin operations at its new location in early December.
